# A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma

> **NCT05322135** · EARLY_PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer

## Interventions

- **DRUG:** 18F-FSPG
- **DRUG:** 11C-Glutamine

## Key facts

- **NCT ID:** NCT05322135
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-14
- **Primary completion:** 2025-03-07
- **Final completion:** 2025-03-07
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** PI Request
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322135, "A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05322135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*